Companies / Daxor Corp

Daxor Corp

Nasdaq: DXRCIK 27367OAK RIDGE, TN

Financials · FY2011

Revenue$1.45M
Net income$-7.19M
Total debt—
Cash$59.6K
Diluted EPS—
Shares outstanding4.2M

Ownership

4.2M shares outstanding
1.1%Insiders
Ownership
Insiders1.06%44,607
Institutions7.83%328,659
Public float91.10%3,822,916

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Jefferies JohnChief Medical Officer
0.56%23,557
Michel Robert JChief Financial Officer
0.50%21,050

Institutional holders 11

View all →
HolderValue% of shares
Vanguard Group Inc$723.2K1.17%
Renaissance Technologies LLC$270.9K0.67%
Nano Cap New Millennium Growth Fund L P$121.5K0.30%
Morgan Stanley$47.7K0.08%
SBI Securities Co., Ltd.$46.1K0.07%
Osaic Holdings, Inc.$7.4K0.01%
Thompson Siegel & Walmsley LLC$2.2K5.53%
UBS Group AG$1.3K<0.01%
Bank of America Corp /De$551<0.01%
JPMorgan Chase & Co$74<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 31, 2026Michel Robert J
Executive
BuyDaxor Common Stock$9.9K+1K
+4.99%
21,050
0.50% of shares
low
Mar 20, 2026Jefferies John
Executive
BuyDaxor Common Stock$0+2K
+10.74%
23,557
0.56% of shares
low
Mar 20, 2026Jefferies John
Executive
BuyDaxor Common Stock$0+4K
+20.75%
21,272
0.51% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DXRCommon StockEquity239467103BBG000BHHF34